Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa, as first-line therapy in patients with metastatic renal cell carcinoma (MRCC) Meeting Abstract
| Authors: | Cella, D.; Michaelson, M. D.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Kim, S. T.; Li, J. Z.; Motzer, R. J. |
| Abstract Title: | Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa, as first-line therapy in patients with metastatic renal cell carcinoma (MRCC) |
| Meeting Title: | International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress |
| Journal Title: | Value in Health |
| Volume: | 12 |
| Issue: | 7 |
| Meeting Dates: | 2009 Oct 24-27 |
| Meeting Location: | Paris, France |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2009-10-01 |
| Start Page: | A283 |
| Language: | English |
| ACCESSION: | ISI:000269878100314 |
| PROVIDER: | wos |
| DOI: | 10.1016/S1098-3015(10)74389-8 |
| Notes: | --- - Meeting Abstract: PCN139 - "Source: Wos" |
